Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ZOLL

TPNS Technology Offered Only by ZOLL’s remedē System Listed in Newly Released Guideline for the Treatment of Central Sleep Apnea
From ZOLL
Via Business Wire
SCD-PROTECT publication: High SCD risk despite modern GDMT across 19,500+ LifeVest® patients
From ZOLL
Via Business Wire
Studies Show Significant Unmet Need in Severe Heart Attack Patients and Cost-Effectiveness of SSO2 Therapy
From ZOLL
Via Business Wire
ZOLL Announces Closing of Acquisition of Select Vyaire Ventilator Product Lines
From ZOLL
Via Business Wire
ZOLL announces successful bid to acquire ventilator business from Vyaire Medical
From ZOLL
Via Business Wire
Late-breaking Analysis From the remedē® System Pivotal Trial Suggests Favorable Outcomes for Heart Failure (HF) Patients With Central Sleep Apnea Receiving Phrenic Nerve Stimulation
From ZOLL
Via Business Wire
ZOLL Receives FDA Clearance and CE Mark to Expand the Thermogard Platform – All-In-One Core and Surface Cooling
From ZOLL
Via Business Wire
ZOLL Reports Recent Data Security Incident
From ZOLL
Via Business Wire
First Patient Enrolled in REAL SSO2 Study to Evaluate Clinical Utility and Economic Value of ZOLL TherOx SSO2 Therapy
From ZOLL
Via Business Wire
ZOLL Awarded Diagnostic and Interventional Cardiology Catheter Agreement with Premier, Inc. for TherOx SuperSaturated Oxygen Therapy
From ZOLL
Via Business Wire
ZOLL Selected to Exhibit TherOx SSO2 Therapy at Vizient Innovative Technology Exchange
From ZOLL
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.